AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Short Interest Down 31.0% in November

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) saw a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 93,400 shares, a decrease of 31.0% from the October 31st total of 135,400 shares. Based on an average daily volume of 1,029,000 shares, the short-interest ratio is presently 0.1 days.

AXIM Biotechnologies Stock Performance

Shares of OTCMKTS:AXIM remained flat at $0.00 during trading on Friday. 21,305 shares of the stock were exchanged, compared to its average volume of 484,896. AXIM Biotechnologies has a 1 year low of $0.00 and a 1 year high of $0.02.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring.